UL Solutions Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Ongoing Certification Services at $1.0 billion, 33% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
|---|---|---|---|
| Revenue |
3,186
|
3,053
|
2,870
|
| Ongoing Certification Services |
1,064
+6.9%
share 33.4%
|
1,006
+5.6%
share 33.0%
|
953
share 33.2%
|
| Non Certification Testing And Other Services |
933
+3.7%
share 29.3%
|
911
+5.9%
share 29.8%
|
860
share 30.0%
|
| Certification Testing |
919
+11.1%
share 28.8%
|
851
+8.5%
share 27.9%
|
784
share 27.3%
|
| Software |
270
-3.9%
share 8.5%
|
285
+4.4%
share 9.3%
|
273
share 9.5%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Testing Laboratories (SIC 8734)
- Listed as
- ULS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Northbrook, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1901440
- Former names
- UL Solutions Inc. (until Nov 4, 2026); UL Inc. (until May 18, 2022)
Other Services-Testing Laboratories companies
- Neogenomics Inc NEO
- 20/20 Biolabs, Inc. AIDX
- Hypha Labs, Inc. FUNI
Source: SEC EDGAR filings. This is company-reported data, not investment advice.